The niacinamide ceiling: when more stops working

There is a concentration above which niacinamide offers no additional benefit and begins to cause irritation in reactive skin types. Most over-the-counter formulations exceed it. The data is not ambiguous.

What the studies show

The original clinical studies establishing niacinamide’s efficacy for barrier function, sebum regulation, and hyperpigmentation were conducted at concentrations of 2% to 5%. The benefits plateau at approximately 5%. Studies using higher concentrations — 10%, 20% — do not show proportionally greater benefit. What they do show, in sensitive skin cohorts, is an increase in flushing, stinging, and erythema.

The flushing mechanism is understood. Niacinamide is a precursor to NAD+. At higher doses, a small amount converts to niacin via a salvage pathway, triggering prostaglandin-mediated vasodilation — the same flush observed with therapeutic niacin doses.

Why the market moved upward

Consumer perception conflates higher concentration with higher efficacy. “10% Niacinamide” communicates strength in a way “5% Niacinamide” does not, despite the clinical evidence showing equivalent or superior outcomes at the lower dose. Formulation cost is also a factor: niacinamide is inexpensive. Going from 5% to 10% costs almost nothing at scale but allows a manufacturer to lead with a number.

The clinical recommendation

For skin concerns addressable by niacinamide — uneven tone, enlarged pores, mild barrier disruption — 2% to 5% is the evidence-based range. For sensitive or reactive skin types, 2% is the starting point. There is no clinical reason to begin at 10%.

If a patient is experiencing stinging, flushing, or increased redness from a niacinamide product, the first question is always concentration. In our clinic, the majority of these presentations resolve immediately on switching to a lower-concentration formulation — not discontinuing niacinamide entirely.